Drawing for PELOTON THERAPEUTICS

USPTO serial 88225205

PELOTON THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DUBOIS, SUSAN L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PELOTON THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa M. Dellamura

Lisa M. Dellamura MERCK & CO., INC.126 E. LINCOLN AVENUEOFFICE OF GENERAL COUNSELRAHWAY, NJ 07065

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension and inflammatory bowel disease; Pharmaceutical preparations for use in the field of oncology; pharmaceutical preparations, namely, medicines for human consumption taken orally for treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension, inflammatory diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodiesACTIVE—
042Pharmaceutical research and development services for research and development of human pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 14, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 14, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 18, 2022DOCKASSIGNED TO EXAMINER—
Jul 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 7, 2021EX4GSOU EXTENSION 4 GRANTED—
Jul 7, 2021EXT4SOU EXTENSION 4 FILED—
Jul 7, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 10, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 10, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jun 10, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 10, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 1, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 30, 2020EX3GSOU EXTENSION 3 GRANTED—
Dec 30, 2020EXT3SOU EXTENSION 3 FILED—
Dec 30, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 25, 2020EX2GSOU EXTENSION 2 GRANTED—
Jun 25, 2020EXT2SOU EXTENSION 2 FILED—
Jun 25, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 1, 2020DOCKASSIGNED TO EXAMINER—
Jan 11, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 9, 2020EX1GSOU EXTENSION 1 GRANTED—
Jan 9, 2020EXT1SOU EXTENSION 1 FILED—
Jan 9, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 8, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 22, 2019WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Oct 22, 2019WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Jul 9, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 14, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 14, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 24, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 31, 2019ALIEASSIGNED TO LIE—
Mar 12, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Mar 12, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 12, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 12, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 8, 2019DOCKASSIGNED TO EXAMINER—
Jan 3, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 14, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance